{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:16:47Z","timestamp":1767651407673},"reference-count":68,"publisher":"American Diabetes Association","issue":"Supplement_2","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,8,1]]},"abstract":"<jats:p>Hypertension is very common in elderly subjects with type 2 diabetes. The coexistence of hypertension and diabetes can be devastating to the cardiovascular system, and in these patients, tight blood pressure (BP) control is particularly beneficial. Little information is available regarding the target BP levels in elderly hypertensive patients with type 2 diabetes, and therefore extrapolation from data in the general population should be done. However, it is difficult to extrapolate from the general population to these frail individuals, who usually have isolated systolic hypertension, comorbidities, organ damage, cardiovascular disease, and renal failure and have a high rate of orthostatic and postprandial hypotension. On the basis of the available evidence, we provide arguments supporting the individualized approach in these patients. Target BP should be based on concomitant diseases, orthostatic BP changes, and the general condition of the patients. It is recommended to lower BP in the elderly patient with diabetes to &amp;lt;140\u2013150\/90 mmHg, providing the patient is in good condition. In patients with isolated systolic hypertension, the same target is reasonable providing the diastolic BP is &amp;gt;60 mmHg. In patients with coronary artery disease and in patients with orthostatic hypotension, excessive BP lowering should be avoided. In elderly hypertensive patients with diabetes, BP levels should be monitored closely in the sitting and the standing position, and the treatment should be tailored to prevent excessive fall in BP.<\/jats:p>","DOI":"10.2337\/dcs15-3027","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T09:52:32Z","timestamp":1469008352000},"page":"S234-S243","update-policy":"http:\/\/dx.doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":19,"title":["What Should Be the Target Blood Pressure in Elderly Patients With Diabetes?"],"prefix":"10.2337","volume":"39","author":[{"given":"Anna","family":"Solini","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehud","family":"Grossman","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Department of Internal Medicine D, Chaim Sheba Medical Center at Tel Hashomer, Tel Aviv, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2016,7,16]]},"reference":[{"key":"2022031221261263700_B1","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"2022031221261263700_B2","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","article-title":"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1\u00b725 million people","volume":"383","author":"Rapsomaniki","year":"2014","journal-title":"Lancet"},{"key":"2022031221261263700_B3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bmj.321.7258.412","article-title":"Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study","volume":"321","author":"Adler","year":"2000","journal-title":"BMJ"},{"key":"2022031221261263700_B4","doi-asserted-by":"crossref","first-page":"41S","DOI":"10.1016\/j.amjhyper.2003.07.009","article-title":"Recommendations for special populations: diabetes mellitus and the metabolic syndrome","volume":"16","author":"Sowers","year":"2003","journal-title":"Am J Hypertens"},{"key":"2022031221261263700_B5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.110.162446","article-title":"Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure","volume":"57","author":"Chen","year":"2011","journal-title":"Hypertension"},{"key":"2022031221261263700_B6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2337\/diacare.25.1.134","article-title":"The treatment of hypertension in adult patients with diabetes","volume":"25","author":"Arauz-Pacheco","year":"2002","journal-title":"Diabetes Care"},{"key":"2022031221261263700_B7","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2010.650","article-title":"US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008","volume":"303","author":"Egan","year":"2010","journal-title":"JAMA"},{"key":"2022031221261263700_B8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/HJH.0b013e328338a89c","article-title":"Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial","volume":"28","author":"Ninomiya","year":"2010","journal-title":"J Hypertens"},{"key":"2022031221261263700_B9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMsa1406751","article-title":"Cost-effectiveness of hypertension therapy according to 2014 guidelines","volume":"372","author":"Moran","year":"2015","journal-title":"N Engl J Med"},{"key":"2022031221261263700_B10","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jacc.2011.01.008","article-title":"ACCF\/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension","volume":"57","author":"Aronow","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2022031221261263700_B11","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/archinte.162.20.2369","article-title":"Orthostatic hypotension in acute geriatric ward: is it a consistent finding","volume":"162","author":"Weiss","year":"2002","journal-title":"Arch Intern Med"},{"key":"2022031221261263700_B12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jash.2015.01.002","article-title":"Prevalence and trends of isolated systolic hypertension among untreated adults in the United States","volume":"9","author":"Liu","year":"2015","journal-title":"J Am Soc Hypertens"},{"key":"2022031221261263700_B13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.jhh.1001458","article-title":"Diuretic induced hyponatraemia in elderly hypertensive women","volume":"16","author":"Sharabi","year":"2002","journal-title":"J Hum Hypertens"},{"key":"2022031221261263700_B14","doi-asserted-by":"crossref","first-page":"d4891","DOI":"10.1136\/bmj.d4891","article-title":"Management of hypertension: summary of NICE guidance","volume":"343","author":"Krause","year":"2011","journal-title":"BMJ"},{"key":"2022031221261263700_B15","first-page":"S49","article-title":"Cardiovascular disease and risk management","volume":"38","author":"American Diabetes Association","year":"2015","journal-title":"Sec. 8. In Standards of Medical Care in Diabetes\u20142015. Diabetes Care"},{"key":"2022031221261263700_B16","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jacc.2013.11.007","article-title":"An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention","volume":"63","author":"Go","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2022031221261263700_B17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jch.12237","article-title":"Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension","volume":"16","author":"Weber","year":"2014","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2022031221261263700_B18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"2022031221261263700_B19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/1715163513487476","article-title":"The 2012-2013 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update","volume":"146","author":"Houle","year":"2013","journal-title":"Can Pharm J (Ott)"},{"key":"2022031221261263700_B20","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"2022031221261263700_B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2012.10.001","article-title":"Global guideline for type 2 diabetes","volume":"104","author":"International Diabetes Federation Guideline Development Group","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031221261263700_B22","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/jgs.12514","article-title":"Guidelines abstracted from the American Geriatrics Society Guidelines for Improving the Care of Older Adults with Diabetes Mellitus: 2013 update","volume":"61","author":"Moreno","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"2022031221261263700_B23","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1161\/CIR.0000000000000207","article-title":"Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension","volume":"131","author":"Rosendorff","year":"2015","journal-title":"Circulation"},{"key":"2022031221261263700_B24","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"2022031221261263700_B25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"},{"key":"2022031221261263700_B26","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"2022031221261263700_B27","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/ajh.2011.77","article-title":"Management of blood pressure in patients with diabetes","volume":"24","author":"Grossman","year":"2011","journal-title":"Am J Hypertens"},{"key":"2022031221261263700_B28","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031221261263700_B29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.2010.884","article-title":"Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease","volume":"304","author":"Cooper-DeHoff","year":"2010","journal-title":"JAMA"},{"key":"2022031221261263700_B30","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"key":"2022031221261263700_B31","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMoa0804593","article-title":"Telmisartan to prevent recurrent stroke and cardiovascular events","volume":"359","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031221261263700_B32","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","article-title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial","volume":"372","author":"Yusuf","year":"2008","journal-title":"Lancet"},{"key":"2022031221261263700_B33"},{"key":"2022031221261263700_B34","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/HJH.0b013e3283469976","article-title":"Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients","volume":"29","author":"Reboldi","year":"2011","journal-title":"J Hypertens"},{"key":"2022031221261263700_B35","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/archinternmed.2012.3147","article-title":"Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus: systematic review and meta-analysis","volume":"172","author":"McBrien","year":"2012","journal-title":"Arch Intern Med"},{"key":"2022031221261263700_B36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(99)07051-8","article-title":"Systolic blood pressure and mortality","volume":"355","author":"Port","year":"2000","journal-title":"Lancet"},{"key":"2022031221261263700_B37"},{"key":"2022031221261263700_B38","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.HYP.0000199667.30253.b7","article-title":"Complex relationship between blood pressure and mortality in type 2 diabetic patients: a follow-up of the Botnia Study","volume":"47","author":"R\u00f6nnback","year":"2006","journal-title":"Hypertension"},{"key":"2022031221261263700_B39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/ageing\/afq080","article-title":"Lower blood pressure associated with higher mortality in elderly diabetic patients (ZODIAC-12)","volume":"39","author":"van Hateren","year":"2010","journal-title":"Age Ageing"},{"key":"2022031221261263700_B40","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031221261263700_B41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12916-015-0328-1","article-title":"No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over","volume":"13","author":"Warwick","year":"2015","journal-title":"BMC Med"},{"key":"2022031221261263700_B42","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1291\/hypres.31.2115","article-title":"Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS)","volume":"31","author":"JATOS Study Group","year":"2008","journal-title":"Hypertens Res"},{"key":"2022031221261263700_B43","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/hr.2010.144","article-title":"Comparison of strict- and mild-blood pressure control in elderly hypertensive patients: a per-protocol analysis of JATOS","volume":"33","author":"Rakugi","year":"2010","journal-title":"Hypertens Res"},{"key":"2022031221261263700_B44","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(98)08127-6","article-title":"Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials","volume":"353","author":"Gueyffier","year":"1999","journal-title":"Lancet"},{"key":"2022031221261263700_B45","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bmj.39548.738368.BE","article-title":"Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials","volume":"336","author":"Turnbull","year":"2008","journal-title":"BMJ"},{"key":"2022031221261263700_B46","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2014.18574","article-title":"Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis","volume":"313","author":"Emdin","year":"2015","journal-title":"JAMA"},{"key":"2022031221261263700_B47","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","author":"Xie","journal-title":"Lancet"},{"key":"2022031221261263700_B48","article-title":"A randomized trial of intensive versus standard blood-pressure control","journal-title":"N Engl J Med"},{"key":"2022031221261263700_B49"},{"key":"2022031221261263700_B50","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/HYPERTENSIONAHA.105.063636","article-title":"Kidney in hypertension: guyton redux","volume":"51","author":"Coffman","year":"2008","journal-title":"Hypertension"},{"key":"2022031221261263700_B51","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijcard.2014.07.067","article-title":"Association of systolic blood pressure levels with cardiovascular events and all-cause mortality among older adults taking antihypertensive medication","volume":"176","author":"Banach","year":"2014","journal-title":"Int J Cardiol"},{"key":"2022031221261263700_B52","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1001\/jama.1996.03540230036032","article-title":"Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension","volume":"276","author":"Curb","year":"1996","journal-title":"JAMA"},{"key":"2022031221261263700_B53","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension","volume":"350","author":"Staessen","year":"1997","journal-title":"Lancet"},{"key":"2022031221261263700_B54","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/archinte.158.15.1681","article-title":"Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly","volume":"158","author":"Staessen","year":"1998","journal-title":"Arch Intern Med"},{"key":"2022031221261263700_B55","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199903043400902","article-title":"Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension","volume":"340","author":"Tuomilehto","year":"1999","journal-title":"N Engl J Med"},{"key":"2022031221261263700_B56","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr039","article-title":"Is a systolic blood pressure target &lt;140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial","volume":"32","author":"Zhang","year":"2011","journal-title":"Eur Heart J"},{"key":"2022031221261263700_B57","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1001\/archinte.159.17.2004","article-title":"The role of diastolic blood pressure when treating isolated systolic hypertension","volume":"159","author":"Somes","year":"1999","journal-title":"Arch Intern Med"},{"key":"2022031221261263700_B58","doi-asserted-by":"crossref","first-page":"438","DOI":"10.7326\/0003-4819-136-6-200203190-00007","article-title":"J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data","volume":"136","author":"Boutitie","year":"2002","journal-title":"Ann Intern Med"},{"key":"2022031221261263700_B59","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/jgs.12381","article-title":"Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study","volume":"61","author":"Solini","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"2022031221261263700_B60","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.ajkd.2015.03.030","article-title":"Midlife blood pressure and late-life GFR and albuminuria: an elderly general population cohort","volume":"66","author":"Inker","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2022031221261263700_B61","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ki.2012.425","article-title":"Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease","volume":"83","author":"Wheeler","year":"2013","journal-title":"Kidney Int"},{"key":"2022031221261263700_B62","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1681\/ASN.2007020256","article-title":"Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study","volume":"18","author":"Perkovic","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2022031221261263700_B63","first-page":"CD008277","article-title":"Blood pressure targets for hypertension in people with diabetes mellitus","volume":"10","author":"Arguedas","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2022031221261263700_B64","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/ndt\/gfv100","article-title":"Clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR &lt;45 mL\/min)","volume":"30","author":"Guideline development group","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2022031221261263700_B65","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/HYPERTENSIONAHA.111.179143","article-title":"Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease: J-curve revisited","volume":"59","author":"Dorresteijn","year":"2012","journal-title":"Hypertension"},{"key":"2022031221261263700_B66","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7326\/0003-4819-144-12-200606200-00005","article-title":"Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous","volume":"144","author":"Messerli","year":"2006","journal-title":"Ann Intern Med"},{"key":"2022031221261263700_B67","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.amjmed.2010.02.014","article-title":"Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy","volume":"123","author":"Denardo","year":"2010","journal-title":"Am J Med"},{"key":"2022031221261263700_B68","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1586\/erc.12.11","article-title":"Identification and management of orthostatic hypotension in older and medically complex patients","volume":"10","author":"Mader","year":"2012","journal-title":"Expert Rev Cardiovasc Ther"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/39\/Supplement_2\/S234\/549237\/dcs153027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/39\/Supplement_2\/S234\/549237\/dcs153027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T23:41:09Z","timestamp":1647128469000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/39\/Supplement_2\/S234\/30301\/What-Should-Be-the-Target-Blood-Pressure-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,16]]},"references-count":68,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2016,7,16]]},"published-print":{"date-parts":[[2016,8,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dcs15-3027","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,16]]}}}